Samuel D. Colella - Jun 24, 2021 Form 4 Insider Report for Flexion Therapeutics Inc (FLXN)

Role
Director
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Stock symbol
FLXN
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
4
Date filed
6/28/2021, 06:32 PM
Next filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLXN Common Stock Award $0 +4.5K +67.18% $0.00 11.2K Jun 24, 2021 Direct F1, F2
holding FLXN Common Stock 1K Jun 24, 2021 The Samuel Colella Trust F2
holding FLXN Common Stock 69.8K Jun 24, 2021 By the Colella Family Trust F3
holding FLXN Common Stock 5K Jun 24, 2021 By the Colella Family Exempt Marital Deduction Trust F4
holding FLXN Common Stock 994K Jun 24, 2021 By Versant Venture Capital III L.P. F5
holding FLXN Common Stock 5.87K Jun 24, 2021 By Versant Side Fund III F6
holding FLXN Common Stock 389K Jun 24, 2021 By Versant Development Fund III, LLC F7
holding FLXN Common Stock 943 Jun 24, 2021 By Colella Partners F8
holding FLXN Common Stock 19.7K Jun 24, 2021 By Colella Partners II F9
holding FLXN Common Stock 250 Jun 24, 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLXN Stock option (right to buy) Award $0 +7K $0.00 7K Jun 24, 2021 Common Stock 7K $9.22 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
F2 Reflects the transfer of 1,000 shares to The Samuel Colella Trust.
F3 The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 ("Colella Trust"). The Reporting Person is a trustee and beneficiary of the Colella Trust.
F4 The shares are held by the Colella Family Exempt Marital Deduction Trust Dated 9/21/1992 ("Colella Exempt Trust"). The Reporting Person is a trustee and beneficiary of the Colella Exempt Trust.
F5 The shares are held by Versant Venture Capital III, L.P. ("VVC III"). The Reporting Person is a managing member of Versant Ventures III, LLC ("VV III"), the sole general partner of VVC III and shares voting and dispositive power over the shares held by VVC III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
F6 The shares are held by Versant Side Fund III, L.P. ("Side Fund III"). The Reporting Person is a managing member of VV III, the sole general partner of Side Fund III and shares voting and dispositive power over the shares held by Side Fund III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
F7 The shares are held by Versant Development Fund III, LLC ("Development III"). The Reporting Person is a managing member of VV III, a majority member of Development III and shares voting and dispositive power over the shares held by Development III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
F8 Shares held by Colella Partners. The Reporting Person is the general partner of Colella Partners.
F9 Shares held by Colella Partners II. The Reporting Person is the general partner of Colella Partners II.
F10 The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant.